CONMED CORPORATION Cost of Revenue
CONMED CORPORATION (CNMD) reported Cost of Revenue of $146.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-07-29
- CONMED CORPORATION cost of goods and services sold for the quarter ending 2026-06-30 was $146.03M, a 5.19% decline year-over-year.
- CONMED CORPORATION cost of goods and services sold for the quarter ending 2025-12-31 was $154.91M, a 4.95% increase year-over-year.
- CONMED CORPORATION cost of goods and services sold for the quarter ending 2025-09-30 was $171.81M, a 24.76% increase year-over-year.
- CONMED CORPORATION cost of goods and services sold for the quarter ending 2025-06-30 was $154.03M, a 3.81% increase year-over-year.
- CONMED CORPORATION cost of goods and services sold for fiscal 2025 was $624.25M, a 8.76% increase from fiscal 2024.
- CONMED CORPORATION cost of goods and services sold for fiscal 2024 was $573.98M, a 0.96% increase from fiscal 2023.
- CONMED CORPORATION cost of goods and services sold for fiscal 2023 was $568.50M, a 19.88% increase from fiscal 2022.
- CONMED CORPORATION cost of goods and services sold for fiscal 2022 was $474.23M, a 7.15% increase from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2026-06-30 | $146.03M 10-Q · filed 2026-07-29 | $279.63M 10-Q · filed 2026-07-29 | ||
| 2025-12-31 | $154.91M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $326.72M derived: sum of 2 quarters · filed 2026-02-17 | $480.75M derived: sum of 3 quarters · filed 2026-07-29 | $624.25M 10-K · filed 2026-02-17 |
| 2025-09-30 | $171.81M 10-Q · filed 2025-11-06 | $325.83M derived: sum of 2 quarters · filed 2026-07-29 | $469.34M 10-Q · filed 2025-11-06 | $616.94M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $154.03M 10-Q · filed 2026-07-29 | $297.53M 10-Q · filed 2026-07-29 | $445.13M derived: sum of 3 quarters · filed 2026-07-29 | $582.84M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $143.50M 10-Q · filed 2025-05-01 | $291.10M derived: sum of 2 quarters · filed 2026-02-17 | $428.81M derived: sum of 3 quarters · filed 2026-02-17 | $577.18M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-12-31 | $147.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $285.31M derived: sum of 2 quarters · filed 2026-02-17 | $433.67M derived: sum of 3 quarters · filed 2026-02-17 | $573.98M 10-K · filed 2026-02-17 |
| 2024-09-30 | $137.71M 10-Q · filed 2025-11-06 | $286.07M derived: sum of 2 quarters · filed 2025-11-06 | $426.38M 10-Q · filed 2025-11-06 | $571.25M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $148.37M 10-Q · filed 2025-07-31 | $288.68M 10-Q · filed 2025-07-31 | $433.55M derived: sum of 3 quarters · filed 2026-02-17 | $570.07M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $140.31M 10-Q · filed 2025-05-01 | $285.18M derived: sum of 2 quarters · filed 2026-02-17 | $421.70M derived: sum of 3 quarters · filed 2026-02-17 | $568.66M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $144.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $281.39M derived: sum of 2 quarters · filed 2026-02-17 | $428.35M derived: sum of 3 quarters · filed 2026-02-17 | $568.50M 10-K · filed 2026-02-17 |
| 2023-09-30 | $136.52M 10-Q · filed 2024-10-31 | $283.48M derived: sum of 2 quarters · filed 2024-10-31 | $423.63M 10-Q · filed 2024-10-31 | $542.63M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $146.96M 10-Q · filed 2024-08-01 | $287.11M 10-Q · filed 2024-08-01 | $406.11M derived: sum of 3 quarters · filed 2025-02-18 | $529.59M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $140.15M 10-Q · filed 2024-04-25 | $259.15M derived: sum of 2 quarters · filed 2025-02-18 | $382.63M derived: sum of 3 quarters · filed 2025-02-18 | $508.04M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $119.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $242.48M derived: sum of 2 quarters · filed 2025-02-18 | $367.89M derived: sum of 3 quarters · filed 2025-02-18 | $474.23M 10-K · filed 2025-02-18 |
| 2022-09-30 | $123.47M 10-Q · filed 2023-10-26 | $248.89M derived: sum of 2 quarters · filed 2023-10-26 | $355.22M 10-Q · filed 2023-10-26 | $473.34M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $125.41M 10-Q · filed 2023-07-27 | $231.75M 10-Q · filed 2023-07-27 | $349.86M derived: sum of 3 quarters · filed 2024-02-28 | $456.38M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $106.34M 10-Q · filed 2023-04-27 | $224.45M derived: sum of 2 quarters · filed 2024-02-28 | $330.97M derived: sum of 3 quarters · filed 2024-02-28 | $444.71M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $118.11M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $224.63M derived: sum of 2 quarters · filed 2024-02-28 | $338.37M derived: sum of 3 quarters · filed 2024-02-28 | $442.60M 10-K · filed 2024-02-28 |
| 2021-09-30 | $106.52M 10-Q · filed 2022-10-27 | $220.26M derived: sum of 2 quarters · filed 2022-10-27 | $324.49M 10-Q · filed 2022-10-27 | $441.80M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-06-30 | $113.74M 10-Q · filed 2022-07-28 | $217.96M 10-Q · filed 2022-07-28 | $335.28M derived: sum of 3 quarters · filed 2023-02-21 | $439.42M derived: sum of 4 quarters · filed 2023-02-21 |
| 2021-03-31 | $104.23M 10-Q · filed 2022-05-05 | $221.54M derived: sum of 2 quarters · filed 2023-02-21 | $325.68M derived: sum of 3 quarters · filed 2023-02-21 | $411.54M derived: sum of 4 quarters · filed 2023-02-21 |
| 2020-12-31 | $117.31M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $221.45M derived: sum of 2 quarters · filed 2023-02-21 | $307.31M derived: sum of 3 quarters · filed 2023-02-21 | $402.16M 10-K · filed 2023-02-21 |
| 2020-09-30 | $104.14M 10-Q · filed 2021-10-28 | $189.99M derived: sum of 2 quarters · filed 2021-10-28 | $284.85M 10-Q · filed 2021-10-28 | $407.73M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $85.86M 10-Q · filed 2021-07-29 | $180.71M 10-Q · filed 2021-07-29 | $303.60M derived: sum of 3 quarters · filed 2022-02-22 | $407.08M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $94.85M 10-Q · filed 2021-04-29 | $217.74M derived: sum of 2 quarters · filed 2022-02-22 | $321.22M derived: sum of 3 quarters · filed 2022-02-22 | $428.29M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $122.89M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $226.37M derived: sum of 2 quarters · filed 2022-02-22 | $333.44M derived: sum of 3 quarters · filed 2022-02-22 | $430.38M 10-K · filed 2022-02-22 |
| 2019-09-30 | $103.48M 10-Q · filed 2020-10-29 | $210.55M derived: sum of 2 quarters · filed 2020-10-29 | $307.49M 10-Q · filed 2020-10-29 | $417.28M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $107.07M 10-Q · filed 2020-07-30 | $204.01M 10-Q · filed 2020-07-30 | $313.80M derived: sum of 3 quarters · filed 2021-02-22 | $405.48M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $96.94M 10-Q · filed 2020-04-30 | $206.73M derived: sum of 2 quarters · filed 2021-02-22 | $298.41M derived: sum of 3 quarters · filed 2021-02-22 | $394.96M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | $109.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $201.47M derived: sum of 2 quarters · filed 2021-02-22 | $298.02M derived: sum of 3 quarters · filed 2021-02-22 | $390.52M 10-K · filed 2021-02-22 |
| 2018-09-30 | $91.68M 10-Q · filed 2019-10-31 | $188.23M derived: sum of 2 quarters · filed 2019-10-31 | $280.74M 10-Q · filed 2019-10-31 | $379.33M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $96.55M 10-Q · filed 2019-08-01 | $189.06M 10-Q · filed 2019-08-01 | $287.65M derived: sum of 3 quarters · filed 2020-02-24 | $375.22M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $92.51M 10-Q · filed 2019-04-26 | $191.10M derived: sum of 2 quarters · filed 2020-02-24 | $278.68M derived: sum of 3 quarters · filed 2020-02-24 | $371.18M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $98.60M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $186.17M derived: sum of 2 quarters · filed 2020-02-24 | $278.67M derived: sum of 3 quarters · filed 2020-02-24 | $365.35M 10-K · filed 2020-02-24 |
| 2017-09-30 | $87.57M 10-Q · filed 2018-11-02 | $180.07M derived: sum of 2 quarters · filed 2018-11-02 | $266.75M 10-Q · filed 2018-11-02 | $363.89M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $92.50M 10-Q · filed 2018-08-02 | $179.18M 10-Q · filed 2018-08-02 | $276.32M derived: sum of 3 quarters · filed 2019-02-25 | $359.90M derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | $86.68M 10-Q · filed 2018-04-26 | $183.82M derived: sum of 2 quarters · filed 2019-02-25 | $267.40M derived: sum of 3 quarters · filed 2019-02-25 | $358.41M derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | $97.14M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $180.72M derived: sum of 2 quarters · filed 2019-02-25 | $271.73M derived: sum of 3 quarters · filed 2019-02-25 | $355.19M 10-K · filed 2019-02-25 |
| 2016-09-30 | $83.58M 10-Q · filed 2017-11-02 | $174.59M derived: sum of 2 quarters · filed 2017-11-02 | $258.06M 10-Q · filed 2017-11-02 | $346.70M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $91.01M 10-Q · filed 2017-07-27 | $174.47M 10-Q · filed 2017-07-27 | $263.11M derived: sum of 3 quarters · filed 2018-02-26 | $338.75M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $83.46M 10-Q · filed 2017-04-27 | $172.10M derived: sum of 2 quarters · filed 2018-02-26 | $247.74M derived: sum of 3 quarters · filed 2018-02-26 | $335.27M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $88.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $164.28M derived: sum of 2 quarters · filed 2018-02-26 | $251.81M derived: sum of 3 quarters · filed 2018-02-26 | $337.47M 10-K · filed 2018-02-26 |
| 2015-09-30 | $75.64M 10-Q · filed 2016-10-28 | $163.17M derived: sum of 2 quarters · filed 2016-10-28 | $248.82M 10-Q · filed 2016-10-28 | $339.80M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $87.53M 10-Q · filed 2016-07-28 | $173.19M 10-Q · filed 2016-07-28 | $264.16M derived: sum of 3 quarters · filed 2017-02-27 | $342.70M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $85.66M 10-Q · filed 2016-05-02 | $176.63M derived: sum of 2 quarters · filed 2017-02-27 | $255.18M derived: sum of 3 quarters · filed 2017-02-27 | $342.30M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $90.97M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $169.52M derived: sum of 2 quarters · filed 2017-02-27 | $256.64M derived: sum of 3 quarters · filed 2017-02-27 | $336.00M 10-K · filed 2017-02-27 |
| 2014-09-30 | $78.55M 10-Q · filed 2015-10-23 | $165.67M derived: sum of 2 quarters · filed 2015-10-23 | $245.03M 10-Q · filed 2015-10-23 | $337.07M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-06-30 | $87.12M 10-Q · filed 2015-07-27 | $166.48M 10-Q · filed 2015-07-27 | $258.53M derived: sum of 3 quarters · filed 2016-02-23 | $342.36M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | $79.36M 10-Q · filed 2015-04-24 | $171.41M derived: sum of 2 quarters · filed 2016-02-23 | $255.24M derived: sum of 3 quarters · filed 2016-02-23 | $345.31M derived: sum of 4 quarters · filed 2016-02-23 |
| 2013-12-31 | $92.05M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $175.88M derived: sum of 2 quarters · filed 2016-02-23 | $265.95M derived: sum of 3 quarters · filed 2016-02-23 | $350.29M 10-K · filed 2016-02-23 |
| 2013-09-30 | $83.83M 10-Q · filed 2014-10-24 | $173.91M derived: sum of 2 quarters · filed 2014-10-24 | $258.24M 10-Q · filed 2014-10-24 | $352.20M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-06-30 | $90.08M 10-Q · filed 2014-07-25 | $174.41M 10-Q · filed 2014-07-25 | $268.37M derived: sum of 3 quarters · filed 2015-02-23 | $352.34M derived: sum of 4 quarters · filed 2015-02-23 |
| 2013-03-31 | $84.33M 10-Q · filed 2014-04-25 | $178.29M derived: sum of 2 quarters · filed 2015-02-23 | $262.26M derived: sum of 3 quarters · filed 2015-02-23 | $352.22M derived: sum of 4 quarters · filed 2015-02-23 |
| 2012-12-31 | $93.96M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $177.93M derived: sum of 2 quarters · filed 2015-02-23 | $267.89M derived: sum of 3 quarters · filed 2015-02-23 | $361.30M 10-K · filed 2015-02-23 |
| 2012-09-30 | $83.97M 10-Q · filed 2013-10-28 | $173.94M derived: sum of 2 quarters · filed 2013-10-28 | $267.34M 10-Q · filed 2013-10-28 | $356.46M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-06-30 | $89.96M 10-Q · filed 2013-07-29 | $183.37M 10-Q · filed 2013-07-29 | $272.49M derived: sum of 3 quarters · filed 2014-02-24 | $354.00M derived: sum of 4 quarters · filed 2014-02-24 |
| 2012-03-31 | $93.41M 10-Q · filed 2013-04-29 | $182.53M derived: sum of 2 quarters · filed 2014-02-24 | $264.03M derived: sum of 3 quarters · filed 2014-02-24 | $355.81M derived: sum of 4 quarters · filed 2014-02-24 |
| 2011-12-31 | $89.13M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $170.63M derived: sum of 2 quarters · filed 2014-02-24 | $262.41M derived: sum of 3 quarters · filed 2014-02-24 | $350.14M 10-K · filed 2014-02-24 |
| 2011-09-30 | $81.50M 10-Q · filed 2012-10-29 | $173.28M derived: sum of 2 quarters · filed 2012-10-29 | $261.02M 10-Q · filed 2012-10-29 | $354.17M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-06-30 | $91.78M 10-Q · filed 2012-07-30 | $179.51M 10-Q · filed 2012-07-30 | $272.67M derived: sum of 3 quarters · filed 2013-02-25 | $355.88M derived: sum of 4 quarters · filed 2013-02-25 |
| 2011-03-31 | $87.73M 10-Q · filed 2012-05-01 | $180.89M derived: sum of 2 quarters · filed 2013-02-25 | $264.10M derived: sum of 3 quarters · filed 2013-02-25 | $351.50M derived: sum of 4 quarters · filed 2013-02-25 |
| 2010-12-31 | $93.15M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-25 | $176.37M derived: sum of 2 quarters · filed 2013-02-25 | $263.77M derived: sum of 3 quarters · filed 2013-02-25 | $348.34M 10-K · filed 2013-02-25 |
| 2010-09-30 | $83.21M 10-Q · filed 2011-11-01 | $170.62M derived: sum of 2 quarters · filed 2011-11-01 | $255.19M 10-Q · filed 2011-11-01 | |
| 2010-06-30 | $87.40M 10-Q · filed 2011-08-09 | $171.97M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $357.41M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |